B. Ojeda

4.0k citations
59 papers · 2.9k · 2 hit papers · h-index 26

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 2%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Peptidase Inhibition and Analysis

Papers in

    • Cancer Treatment and Pharmacology 13
    • HER2/EGFR in Cancer Research 9
    • Breast Cancer Treatment Studies 14

B. Ojeda

58 papers receiving 2.8k citations

B. Ojeda's Hit Papers

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort 2014 · 364 citations
3640+5+10Years since publication250500750

Peers

B. Ojeda
Comparison fields: 5 of 96
  • Cancer Research 830
  • Oncology 1.4k
  • Reproductive Medicine 243
  • Family Practice 44
  • Radiology, Nuclear Medicine and Imaging 487
Replace Jean‐Pierre Lotz with:
Jean‐Pierre Lotz France
Elie Rassy Lebanon
Henrik Lindman Sweden
Carlo Tondini Italy
C. J. Rodenburg Netherlands
Seong Hyeon Yun South Korea
Laura Orlando Italy
Maria Carmela Piccirillo Italy
Claus Kamby Denmark
Ninja Antonini Netherlands
B. Ojeda relative to Jean‐Pierre Lotz France Jean‐Pierre Lotz's profile →
Citations per field
00.5×6.3×
Jean‐Pierre Lotz · 1×
Citations per year

Countries citing papers authored by B. Ojeda

Since Specialization
Citations

This map shows the geographic impact of B. Ojeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Ojeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Ojeda more than expected).

Fields of papers citing papers by B. Ojeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Ojeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Ojeda. The network helps show where B. Ojeda may publish in the future.

Co-authors

The 25 scholars most cited alongside B. Ojeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Ojeda Line = papers co-authored together B. Ojeda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
Hit paper breakdown →
2010923
2
Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort
Hit paper breakdown →
2014364
3 2012198
4
Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer.
2000141
5 200599
6 200480
7
Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer.
199079
8 200769
9 201265
10 199864
11 199755
12 199253
13 202047
14 200845
15 199145
16 201544
17 199442
18 199340
19 200338
20 200235

About B. Ojeda

B. Ojeda is a scholar working on Oncology, Cancer Research, Reproductive Medicine, Pulmonary and Respiratory Medicine and Surgery, having authored 59 papers that have together received 2.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (14 papers), Cancer Treatment and Pharmacology (13 papers), Ovarian cancer diagnosis and treatment (13 papers), HER2/EGFR in Cancer Research (9 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Endometrial and Cervical Cancer Treatments (5 papers), Advanced Breast Cancer Therapies (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Cancer Research (830 citations), Oncology (1.4k citations), Reproductive Medicine (243 citations), Family Practice (44 citations) and Radiology, Nuclear Medicine and Imaging (487 citations). B. Ojeda has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Aňa Lluch, Eva Ciruelos, Pinuccia Valagussa, Semiglazov Vf, Milvia Zambetti, W. Eiermann, Federico Vázquez, А. А. Божок, Miguel Ángel Climent and Luca Gianni. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Acta Oncologica, Breast Cancer Research and Treatment and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact